Nuclear Medicine/ Radiopharmaceuticals Market with New Growth Prospect By Top Key Players

Global Nuclear Medicine/ Radiopharmaceuticals Market is valued approximately at USD 3.95 Billion in 2018 and is anticipated to grow with a growth rate of more than 5.90% over the forecast period 2019-2026. Nuclear medicine is medical specialty that uses radioactive tracers (radiopharmaceutical) to determine bodily function and to diagnose and treat disease. It is featured with designed camera that allows doctor to track the path of these radioactive trackers. In nuclear medication, Single Photon Emission Computed Tomography (SPECT) and Positron Emission Tomography (PET) are common imaging scanning those are widely used in end-use industry. Nuclear medicine is implemented in human body by injecting radioactive material (radiopharmaceuticals or radiotracers) that can easily be detected on the PET scan. Radiotracers are commonly used in cancer treatment as it contains fluorodeoxyglucose that is a molecule like glucose. Cancer cells are metabolically active and absorb glucose at a higher speed that can easily be detected by PET scans. Therefore, efficient application of Nuclear medicine in cancer detection coupled with rising cancer cases across the globe accelerate the growth of market over the forecast years. For instance: According to the International Agency for Research on Cancer (IARC) 2018, over 17 Billion new cancer cases were registered in 2018. Additionally, increasing incidence and prevalence of target conditioning is the factor driving the growth of market over the upcoming years. Whereas, application of radiopharmaceuticals in neurological disorders is an opportunity for the market growth. However, short life of radiopharmaceuticals are the factors hamper the growth of market over the forecast years.

Click Here to Download Sample Report >>https://www.kennethresearch.com/sample-request-10265736

The regional analysis of global Nuclear Medicine/ Radiopharmaceuticals market is considered for the key regions such as Asia Pacific, North America, Europe, Latin America and Rest of the World. North America accounts for the largest share in the global Nuclear Medicine market due to the increased better infrastructure facility in the health care sector. Similarly, North America is the fastest growing region in the market owing to the effectiveness of a diagnosis procedure for the early detection such as cancer and cardiac diseases.

Market player included in this report are:
Cardinal Health
Positron Corporation
GE Healthcare
Curium
Lantheus Medical Imaging
Bayer
Bracco Imaging
Eczacibasi-Monrol Nuclear Products
Nordion
Advanced Accelerator Applications

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:

By Type:
Diagnostic Nuclear Medicine
Therapeutic Nuclear Medicine
By Application:
Diagnostic Application
Therapeutic application
By Procedural Volume:
Diagnostic procedures
Therapeutic procedures

By Regions:
North America
U.S.
Canada
Europe
UK
Germany
Asia Pacific
China
India
Japan
Latin America
Brazil
Mexico
Rest of the World

Furthermore, years considered for the study are as follows:

Historical year – 2016, 2017
Base year – 2018
Forecast period – 2019 to 2026

Target Audience of the Global Nuclear Medicine/ Radiopharmaceuticals Market in Market Study:

Key Consulting Companies & Advisors
Large, medium-sized, and small enterprises
Venture capitalists
Value-Added Resellers (VARs)
Third-party knowledge providers
Investment bankers
Investors
Investors

Click Here to Download Sample Report >>https://www.kennethresearch.com/sample-request-10265736

Chapter 1. Executive Summary
1.1. Market Snapshot
1.2. Global & Segmental Market Estimates & Forecasts, 2017-2026 (USD Billion)
1.2.1. Nuclear Medicine/ Radiopharmaceuticals Market, by Region, 2017-2026 (USD Billion)
1.2.2. Nuclear Medicine/ Radiopharmaceuticals Market, by Type ,2017-2026 (USD Billion)
1.2.3. Nuclear Medicine/ Radiopharmaceuticals Market, by Application,2017-2026 (USD Billion)
1.2.4. Nuclear Medicine/ Radiopharmaceuticals Market, by Procedural Volume, 2017-2026 (USD Billion)
1.3. Key Trends
1.4. Estimation Methodology
1.5. Research Assumption
Chapter 2. Global Nuclear Medicine/ Radiopharmaceuticals Market Definition and Scope
2.1. Objective of the Study
2.2. Market Definition & Scope
2.2.1. Scope of the Study
2.2.2. Industry Evolution
2.3. Years Considered for the Study
2.4. Currency Conversion Rates
Chapter 3. Global Nuclear Medicine/ Radiopharmaceuticals Market Dynamics
3.1. Nuclear Medicine/ Radiopharmaceuticals Market Impact Analysis (2018-2026)
3.1.1. Market Drivers
3.1.2. Market Challenges
3.1.3. Market Opportunities
Chapter 4. Global Nuclear Medicine/ Radiopharmaceuticals Market Industry Analysis
4.1. Porter’s 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.1.6. Futuristic Approach to Porter’s 5 Force Model (2016-2026)
4.2. PEST Analysis
4.2.1. Political
4.2.2. Economical
4.2.3. Social
4.2.4. Technological
4.3. Investment Adoption Model
4.4. Analyst Recommendation & Conclusion
Chapter 5. Global Nuclear Medicine/ Radiopharmaceuticals Market, by Type
5.1. Market Snapshot
5.2. Global Nuclear Medicine/ Radiopharmaceuticals Market by Type, Performance – Potential Analysis
5.3. Global Nuclear Medicine/ Radiopharmaceuticals Market Estimates & Forecasts by Type 2016-2026 (USD Billion)
5.4. Nuclear Medicine/ Radiopharmaceuticals Market, Sub Segment Analysis
5.4.1. Diagnostic Nuclear Medicine
5.4.2. Therapeutic Nuclear Medicine
Chapter 6. Global Nuclear Medicine/ Radiopharmaceuticals Market, by Application
6.1. Market Snapshot
6.2. Global Nuclear Medicine/ Radiopharmaceuticals Market by Application, Performance – Potential Analysis
6.3. Global Nuclear Medicine/ Radiopharmaceuticals Market Estimates & Forecasts by Application 2016-2026 (USD Billion)
6.4. Nuclear Medicine/ Radiopharmaceuticals Market, Sub Segment Analysis
6.4.1. Diagnostic Application
6.4.2. Therapeutic Application
Chapter 7. Global Nuclear Medicine/ Radiopharmaceuticals Market, by Procedural Volum

About Kenneth Research

Kenneth Research is a reselling agency providing market research solutions in different verticals such as Automotive and Transportation, Chemicals and Materials, Healthcare, Food & Beverage and Consumer Packaged Goods, Semiconductors, Electronics & ICT, Packaging, and Others. Our portfolio includes set of market research insights such as market sizing and market forecasting, market share analysis and key positioning of the players (manufacturers, deals and distributors, etc), understanding the competitive landscape and their business at a ground level and many more. Our research experts deliver the offerings efficiently and effectively within a stipulated time. The market study provided by Kenneth Research helps the Industry veterans/investors to think and to act wisely in their overall strategy formulation

Contact Us

Kenneth Research
Email: Sales@kennethresearch.com
Phone: +1 313 462 0609

Eli is a freelance writer and possess double graduation degree in physics and chemistry. She is an intense writer covering everything for Science and Tech to Business, Entertainment, Sports and Lifestyle.

Leave a Reply